NASDAQ$LAB
Standard Biotool · Q1 2024 earnings
Q1 2024 earnings · · Investor relations
Briefing
LAB Q1 2024 — $23.9M revenue, 31.00 EPS
Forward-looking statements include information concerning our possible or assumed future cash flow, revenue, sources of revenue and results of operations, cost of product revenue and product margin, o. Standard Biotool reported Q1 2024 results. Diluted EPS came in at $31.00. Net income of $40.0M. Headline numbers extracted from the Form 10-Q press release; narrative is light because this row was processed without an LLM call.
- Revenue: $23.9M.
- Diluted EPS: $31.00.
- Net income: $40.0M.
- Operating income: $60K.
- Gross profit: $24K.
Headline financials
Revenue & EPS history
Standard Biotool · Revenue · Quarterly
$45.5M
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2024
-2.7%
Avg return
Earnings day
-0.8%
Avg return
5 days after
+0.6%
Avg return
30 days after
42%
19 / 45 earnings
Positive
+44.5%
Q3 2015
Best reaction
-51.0%
Q3 2019
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -1.0% | +1.0% | +16.3% | |
| Q4 2025 | +2.6% | -4.3% | -21.7% | |
| Q3 2025 | -2.6% | +0.0% | +26.1% | |
| Q1 2025 | -3.9% | +9.4% | +0.0% | |
| Q4 2024 | -10.3% | -9.4% | -2.6% | |
| Q3 2024 | +12.0% | +5.7% | -13.7% | |
| Q2 2024 | -38.8% | -31.5% | -8.2% | |
| Q1 2024 | +1.7% | +4.6% | -2.1% | |
| Q4 2023 | -3.8% | +10.3% | +15.8% | |
| Q3 2023 | -6.9% | +6.9% | +15.2% | |
| Q2 2023 | +6.7% | +20.0% | +20.8% | |
| Q1 2023 | +9.1% | +7.3% | +33.9% | |
| Q4 2022 | +0.0% | -0.5% | +3.3% | |
| Q3 2022 | -7.9% | +32.7% | +29.7% | |
| Q2 2022 | -11.1% | -6.9% | -22.8% | |
| Q1 2022 | -5.8% | -21.4% | -37.1% | |
| Q4 2021 | +3.1% | -1.4% | +8.0% | |
| Q3 2021 | -5.1% | +0.8% | -8.2% | |
| Q2 2021 | -7.0% | -0.7% | +4.7% | |
| Q1 2021 | +5.1% | +12.5% | +12.1% | |
| Q4 2020 | -19.8% | -20.5% | -35.2% | |
| Q3 2020 | +13.5% | -18.2% | -7.7% | |
| Q2 2020 | +2.6% | +0.1% | -17.3% | |
| Q1 2020 | +15.9% | +31.9% | +0.0% | |
| Q4 2019 | -0.3% | -3.7% | -30.6% | |
| Q3 2019 | -51.0% | -54.5% | -51.0% | |
| Q2 2019 | -31.5% | -40.0% | -52.5% | |
| Q1 2019 | -10.4% | -13.2% | -1.4% | |
| Q4 2018 | +10.4% | +17.5% | +37.4% | |
| Q3 2018 | +2.1% | +1.7% | +13.9% | |
| Q2 2018 | +7.0% | +8.4% | +26.1% | |
| Q1 2018 | -2.2% | -7.1% | -5.3% | |
| Q4 2017 | +13.4% | +30.3% | +17.8% | |
| Q3 2017 | +1.8% | -7.4% | +4.7% | |
| Q2 2017 | -3.1% | -4.9% | +44.9% | |
| Q1 2017 | +17.3% | +16.1% | -3.6% | |
| Q4 2016 | -1.6% | +0.3% | -18.1% | |
| Q3 2016 | -1.8% | +11.1% | +48.8% | |
| Q2 2016 | -12.2% | -13.4% | -15.8% | |
| Q1 2016 | +5.4% | — | — | |
| Q4 2015 | +0.0% | — | — | |
| Q3 2015 | +44.5% | — | — | |
| Q2 2015 | -35.8% | — | — | |
| Q1 2015 | -26.4% | — | — | |
| Q4 2014 | +2.2% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro